Savara

$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+6.62%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Savara and other stocks, options, and ETFs commission-free!

About SVRA

Savara Inc. Common Stock, also called Savara, is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX. The listed name for SVRA is Savara Inc. Common Stock.

CEO

Matthew Pauls

Employees

Headquarters

Austin, Texas

Founded

2017

Market Cap

77.93M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

396.86K

High Today

$1.48

Low Today

$1.30

Open Price

$1.33

Volume

759.47K

52 Week High

$3.95

52 Week Low

$0.9952

Collections

SVRA Earnings

-$0.57

-$0.38

-$0.19

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours